PlainRecalls
FDA Drug Moderate Class II Terminated

Valganciclovir Hydrochloride for Oral Solution, 50 mg/mL, 100 mL (3.4 fl. oz.) bottle, Rx only, Manufactured for: Actavis Laboratories FL. Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-2579-20

Reported: November 27, 2019 Initiated: November 4, 2019 #D-0518-2020

Product Description

Valganciclovir Hydrochloride for Oral Solution, 50 mg/mL, 100 mL (3.4 fl. oz.) bottle, Rx only, Manufactured for: Actavis Laboratories FL. Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-2579-20

Reason for Recall

Presence of foreign substance: Brown/black particles found during stability testing.

Details

Units Affected
3,623 bottles
Distribution
Product was distributed to wholesalers/distributors throughout the United States.
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Valganciclovir Hydrochloride for Oral Solution, 50 mg/mL, 100 mL (3.4 fl. oz.) bottle, Rx only, Manufactured for: Actavis Laboratories FL. Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-2579-20. Recalled by Teva Pharmaceuticals USA, Inc.. Units affected: 3,623 bottles.
Why was this product recalled?
Presence of foreign substance: Brown/black particles found during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 27, 2019. Severity: Moderate. Recall number: D-0518-2020.